Basic Information
ID: ALA5118634
Type: Binding
Description: Inhibition of CD22 in human Daudi cells assessed as relative inhibitory potency in presence of biotinylated dimeric 2-(78-biotinoylamino-1,4,7,10,13,16-hexaoxa-octadecyl)-1,4-bis(2-aza-l-oxo-8-(sodium(5-acetamido-3,5,9-trideoxy-9-(4-phenylbenzamido)-D-glycero-a-D-galacto-non-2-ulopyranosyloxyonate))-5-thia-octyl) benzene preincubated for 15 mins followed by probe addition incubated for 20 mins by flow cytometric analysis relative to 1,4-bis-(2-Aza-1-oxo-8-(sodium(5-acetamido-3,5,9-trideoxy-9-(4-phenylbenzamido)-D-glycero-alpha-D-galacto-non-2-ulopyranosyloxyonate))-5-thia-octyl)benzene
Organism: Homo sapiens
Cell type: Daudi
Activity Charts
Bioactivity
Activity Types for Assay ALA5118634
FC
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 1027.04 | -4.28 | -4.28 |
| 1417.48 | ||
| 1587.61 | ||
| 1464.38 | ||
| 1357.52 | ||
| 1461.58 | ||
| 1781.96 | ||
| 1409.60 | ||
| 1365.50 | ||
| 1395.40 | ||
| 1385.49 | ||
| 1454.38 | ||
| 1399.35 | ||
| 1866.94 | ||
| 1391.51 | ||
| 1397.54 | ||
| 1385.49 | ||
| 1664.82 | ||
| 1397.58 |